Position in ZTS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$24,587
-$2,841 QoQ
Shares Held
208
-4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GW&K Investment Management, LLC holds $163,730,959 across 8 Drug Manufacturers - Specialty & Generic names. ZTS ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
593,725 | $78,217,331 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,055,184 | $54,542,460 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
3,240,462 | $30,849,197 | |
| 4 | VTRS |
Viatris Inc
|
2,967 | $40,084 | |
| 5 | HLN |
Haleon plc
|
3,869 | $38,728 | |
| 6 | ZTS |
Zoetis Inc.
This page
|
208 | $24,587 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
580 | $10,741 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
260 | $7,831 |
All Filings in ZTS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,587 | 208 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $27,428 | 218 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $47,554 | 325 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $45,381 | 291 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $50,712 | 308 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $50,019 | 307 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $59,786 | 306 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $47,674 | 275 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $41,287 | 244 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $33,947 | 172 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $24,879 | 143 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $21,698 | 126 | Shares | Sole | 2023-08-09 | |
| 2022-12-31 | $4,689 | 32 | Shares | Sole | 2023-02-10 | |
| 2022-06-30 | $260,757 | 1,517 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $197,830 | 1,049 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $11,225 | 46 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,077,671 | 5,551 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $9,122,135 | 48,949 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $15,048,158 | 95,556 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $19,853,214 | 119,959 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $19,825,878 | 119,888 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $16,588,006 | 121,045 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $12,074,758 | 102,598 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||